Predictive factors of revision endoscopic sinus surgery

Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3265-3269. doi: 10.1007/s00405-023-07856-7. Epub 2023 Feb 10.

Abstract

Purpose: Despite endoscopic sinus surgery (ESS) being the standard best treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), there still remains a high recurrence rate of nasal polyps after ESS. The aim of this study was to analyze the impact of ESS in the treatment of CRSwNP and identify possible predictors for revision surgery.

Methods: We conducted a cross-sectional retrospective study of patients with CRSwNP submitted to ESS between the years 2013 and 2021.

Results: We analyzed 517 cases, of which 15.1% were submitted to revision ESS. The presence of hyposmia/anosmia, asthma, intolerance/allergy to non-steroid inflammatory drugs, non-steroidal anti-inflammatory drug exacerbated respiratory disease, and bilateral polyposis were more frequent in patients who needed revision surgery. Initial values of peripheral eosinophilia and Lund-Mackay scores were significantly higher in this sub-group of patients. Lund-Mackay score was the only independent risk factor for revision surgery.

Conclusions: Factors like peripheral eosinophilia and Lund-Mackay score were associated with a higher probability of revision ESS. Applying these concepts to the clinical practice could help predict the evolution of patient's pathology in the post-operative period and identify in advance those cases that may need a multidisciplinary approach.

Keywords: Chronic rhinosinusitis; Endoscopic sinus surgery; Eosinophils; Nasal polyps; Revision sinus surgery.

MeSH terms

  • Chronic Disease
  • Cross-Sectional Studies
  • Endoscopy
  • Eosinophilia*
  • Humans
  • Nasal Polyps* / complications
  • Nasal Polyps* / surgery
  • Retrospective Studies
  • Rhinitis* / complications
  • Rhinitis* / surgery
  • Sinusitis* / complications
  • Sinusitis* / surgery